Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3671)
All Articles published online
|
Publishing Process of This Article
|
Oct 24, 2022 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Solé S, Becerra S, Carvajal C, Bettolli P, Letelier H, Santini A, Vargas L, Cifuentes A, Larsen F, Jara N, Oyarzún J, Bustamante E, Martínez B, Rosenberg D, Galván T. Clinical relevance of the use of Dentoxol® for oral mucositis induced by radiotherapy: A phase II clinical trial. World J Clin Oncol 2022; 13(10): 813-821 [PMID: 36337310 DOI: 10.5306/wjco.v13.i10.813] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v13/i10/813.htm |
| Number | Citing Articles |
| 1 |
Margherita Gobbo, Jamie Joy, Helena Guedes, Muhammad Ali Shazib, Carryn Anderson, Ragda Abdalla-Aslan, Khunthong Peechatanan, Carlo Lajolo, Khawaja Shehryar Nasir, Luiz Alcino Gueiros, Nivethitha Nagarajan, Kimia Hafezi Motlagh, Abhishek Kandwal, Cosimo Rupe, Yuanming Xu, Eli D. Ehrenpreis, Arghavan Tonkaboni, Joel B. Epstein, Paolo Bossi, Hannah R. Wardill, Stephanie L. Graff. Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents. Expert Opinion on Pharmacotherapy 2024; 25(6): 727 doi: 10.1080/14656566.2024.2354451
|